Finch Therapeutics Group, Inc.
FNCH · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -1.5% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -163% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -106.9% | – |
| EPS Diluted | -3.01 | -2.41 | -1.89 | -1.51 |
| % Growth | -24.9% | -27.5% | -25.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |